控訴審、争点、及び法的戦略
About
控訴審、特に知的財産に関わるものは、細部に至るまで細心の注意を払う必要があります。また、法律と事実の両方を徹底的に理解し、控訴審の陪審員団を説得できる可能性が最も高い 主張を一つか二つ特定することが要求されます。弊所は、控訴審の準備書面及び口頭弁論の質の高さで広く知られています。同時に、控訴審のプロセスは、控訴が提起されるずっと前から始まることが多いことも理解しています。弊所の上訴担当弁護士は、あらゆる場面を想定した法的思考力と熟練した執筆力を備えており、裁判チームと協力して法的戦略を策定し、勝利のための準備書面、上訴を見据えた問題を適切に見極めることができます。
Practice Areas
PTAB決定に対する異議申立
特許審判部（PTAB）の決定は連邦巡回控訴裁判所に直接上訴されます。
連邦巡回控訴裁判所および最高裁判所
控訴審では、細部に至るまで細心の注意を払う必要があり、説得力が最も期待できる1つか2つの主張を見極めるために、控訴審法を十分に理解する必要があります。
特許の異議申立及び不服申立
特許異議申立や特許取消の手続は、特許付与後の限られた期間内に第三者が特許に異議を唱える機会を提供するものです。
実績
Obtained a $240 million jury verdict for client Promptu in a patent infringement lawsuit against Comcast. The jury found that Comcast willfully infringed Promptu’s patents covering voice recognition technology for TV.
2:16-cv-06516, E.D. Pa., Judge Sanchez
22-1939, Fed. Cir., Judges Prost, Moore, Taranto
Obtained complete victory against Carrum on appeal of the District of Delaware’s claim construction to the Federal Circuit following Carrum’s stipulation of non-infringement under the claim construction, thereby exonerating BMW’s ACC system, first sold in 2000, against Carrum’s 2004 patents. Invalidated several asserted claims through post-grant efforts before the U.S. Patent Office, including IPRs and EPRs, and pursued claims through proceedings before the Eastern District of Virginia to vindicate BMW’s patent challenges.
1:18-cv-01645, D. Del., Judge Andrews
21-1435, 24-1480, Fed. Cir., Judges Clevenger, Cunningham, Lourie, Moore, Prost, Taranto
IPR2019-00902, -00903, -00904, -00905, -00927, 00928, PTAB, Judges Browne, Scanlon, Tornquist
90/019,010, CRU
Finnegan represented Bausch & Lomb’s licensee Eye Therapies, LLC in an appeal at the U.S. Court of Appeals for the Federal Circuit from a Patent Trial and Appeal Board (PTAB) decision finding Eye Therapies’ patent directed to a low-dose brimonidine treatment for eye redness (Lumify®) to be unpatentable. In a precedential decision, the Federal Circuit agreed with Finnegan’s arguments and found that the Board had wrongly invalidated the patent based on an incorrect claim construction, vacating and remanding the case back to the PTAB. The proceeding settled shortly thereafter
23-2173, Fed. Cir., Judges Taranto, Stoll, Scarsi
Secured a significant victory for client US Synthetic Corporation (USS) with a precedential decision from the U.S. Court of Appeals for the Federal Circuit (CAFC) overturning an unfavorable 35 U.S.C. § 101 eligibility ruling from the International Trade Commission (ITC).
23-1217, Fed. Cir., Judges Chen, Dyk, Stoll
Secured a covenant-not-to-sue and zero-dollar walkaway for BMW Group in a declaratory judgment action, concluding Arigna’s high-profile patent enforcement campaign involving current amplification technology. This outcome follows a decisive ITC victory, the dismissal of parallel District Court litigation, and multiple concurrent patent office challenges pending at the time of resolution.
1:23-cv-01190, D.D.C., Judge Contreras
2:21-cv-00173, E.D. Tex.
IPR2021-01531, PTAB, Judges Baer, Fenick, Iftikhar
23-1931, Fed. Cir.
90/019,261, USPTO
In a rare rehearing proceeding, successfully represented petitioner Incyte in an inter partes review (IPR) challenging the validity of Concert’s patent before the Patent Trial and Appeal Board (PTAB). Continued representation of appellee Incyte before the Federal Circuit and secured a unanimous affirmance of the PTAB’s obviousness determination.
IPR2017-01256, PTAB, Judges Fitzpatrick, Hulse, Yang, Smith, Franklin
19-2011, Fed. Cir., Judges Hughs, Linn, Stark
